{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T14:24:27Z","timestamp":1768746267997,"version":"3.49.0"},"reference-count":35,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Impairment of the nitric oxide\/soluble guanylate cyclase (NO)\/sGC) signalling cascade is associated with many forms of cardiovascular disease, resulting not only in compromised vasodilatation but also loss of anti-aggregatory homeostasis. Myocardial ischaemia, heart failure, and atrial fibrillation are associated with moderate impairment of NO\/sGC signalling, and we have recently demonstrated that coronary artery spasm (CAS) is engendered by severe impairment of platelet NO\/sGC activity resulting in combined platelet and vascular endothelial damage. We therefore sought to determine whether sGC stimulators or activators might normalise NO\/sGC homeostasis in platelets. ADP-induced platelet aggregation and its inhibition by the NO donor sodium nitroprusside (SNP), the sGC stimulator riociguat (RIO), and the sCG activator cinaciguat (CINA) alone or in addition to SNP were quantitated. Three groups of individuals were compared: normal subjects (n = 9), patients (Group 1) with myocardial ischaemia, heart failure and\/or atrial fibrillation (n = 30), and patients (Group 2) in the chronic stage of CAS (n = 16). As expected, responses to SNP were impaired (p = 0.02) in patients versus normal subjects, with Group 2 patients most severely affected (p = 0.005). RIO alone exerted no anti-aggregatory effects but potentiated responses to SNP to a similar extent irrespective of baseline SNP response. CINA exerted only intrinsic anti-aggregatory effects, but the extent of these varied directly (r = 0.54; p = 0.0009) with individual responses to SNP. Thus, both RIO and CINA tend to normalise anti-aggregatory function in patients in whom NO\/sGC signalling is impaired. The anti-aggregatory effects of RIO consist entirely of potentiation of NO, which is not selective of platelet NO resistance. However, the intrinsic anti-aggregatory effects of CINA are most marked in individuals with initially normal NO\/sGC signalling, and thus their magnitude is at variance with extent of physiological impairment. These data suggest that RIO and other sGC stimulators should be evaluated for clinical utility in both prophylaxis and treatment of CAS.<\/jats:p>","DOI":"10.3390\/ijms24119273","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T02:05:44Z","timestamp":1685066744000},"page":"9273","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of Soluble Guanylate Cyclase Stimulators and Activators on Anti-Aggregatory Signalling in Patients with Coronary Artery Spasm"],"prefix":"10.3390","volume":"24","author":[{"given":"Armin","family":"Muminovic","sequence":"first","affiliation":[{"name":"Basil Hetzel Institute for Translational Research, University of Adelaide, 37a Woodville Road, Adelaide, SA 5011, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuliy Y.","family":"Chirkov","sequence":"additional","affiliation":[{"name":"Basil Hetzel Institute for Translational Research, University of Adelaide, 37a Woodville Road, Adelaide, SA 5011, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Horowitz","sequence":"additional","affiliation":[{"name":"Basil Hetzel Institute for Translational Research, University of Adelaide, 37a Woodville Road, Adelaide, SA 5011, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1161\/ATVBAHA.117.309813","article-title":"Endothelial Functions","volume":"37","author":"Godo","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/288373a0","article-title":"The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine","volume":"288","author":"Furchgott","year":"1980","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0021-9150(89)90109-3","article-title":"Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation","volume":"76","author":"Booth","year":"1989","journal-title":"Atherosclerosis"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/CIRCRESAHA.107.158410","article-title":"Platelet-derived nitric oxide signaling and regulation","volume":"101","author":"Gkaliagkousi","year":"2007","journal-title":"Circ. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/apha.12646","article-title":"Endothelial dysfunction and vascular disease\u2014A 30th anniversary update","volume":"219","author":"Vanhoutte","year":"2017","journal-title":"Acta Physiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure","volume":"339","author":"Vallance","year":"1992","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Daiber, A., Xia, N., Steven, S., Oelze, M., Hanf, A., Kr\u00f6ller-Sch\u00f6n, S., M\u00fcnzel, T., and Li, H. (2019). New Therapeutic Implications of Endothelial Nitric Oxide Synthase (eNOS) Function\/Dysfunction in Cardiovascular Disease. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20010187"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/01.CIR.101.16.1899","article-title":"Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease","volume":"101","author":"Britten","year":"2000","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacc.2006.08.053","article-title":"The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes mediation by superoxide production, resolution with intensive insulin administration","volume":"49","author":"Worthley","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.pharmthera.2007.06.012","article-title":"Impaired tissue responsiveness to organic nitrates and nitric oxide: A new therapeutic frontier?","volume":"116","author":"Chirkov","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"18b","DOI":"10.1016\/0002-9149(92)90590-U","article-title":"Antiplatelet and antithrombotic effects of organic nitrates","volume":"70","author":"Loscalzo","year":"1992","journal-title":"Am. J. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1172\/JCI119540","article-title":"Nitric oxide released from activated platelets inhibits platelet recruitment","volume":"100","author":"Freedman","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/14779072.2021.1991314","article-title":"Angina due to coronary artery spasm (variant angina): Diagnosis and intervention strategies","volume":"19","author":"Nguyen","year":"2021","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4330\/wjc.v10.i11.201","article-title":"Coronary spasm: It\u2019s common, but it\u2019s still unsolved","volume":"10","author":"Teragawa","year":"2018","journal-title":"World J. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/bph.15388","article-title":"Impairment of platelet NO signalling in coronary artery spasm: Role of hydrogen sulphide","volume":"178","author":"Imam","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/01.CIR.100.2.129","article-title":"Nitrate resistance in platelets from patients with stable angina pectoris","volume":"100","author":"Chirkov","year":"1999","journal-title":"Circulation"},{"key":"ref_17","first-page":"65","article-title":"Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation","volume":"249","author":"Murad","year":"1987","journal-title":"Prog. Clin. Biol. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/164_2018_197","article-title":"Soluble Guanylate Cyclase Stimulators and Activators","volume":"264","author":"Sandner","year":"2021","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000063121","article-title":"The coronary slow flow phenomenon\u2014A new coronary microvascular disorder","volume":"97","author":"Beltrame","year":"2002","journal-title":"Cardiology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/CIRCULATIONAHA.113.004096","article-title":"Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries","volume":"129","author":"Ong","year":"2014","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jacc.2012.01.066","article-title":"Ramipril sensitizes platelets to nitric oxide: Implications for therapy in high-risk patients","volume":"60","author":"Willoughby","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1053\/euhj.2002.3296","article-title":"Beneficial clinical effects of perhexiline in patients with stable angina pectoris and acute coronary syndromes are associated with potentiation of platelet responsiveness to nitric oxide","volume":"23","author":"Willoughby","year":"2002","journal-title":"Eur. Heart J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1440-1681.2003.03859.x","article-title":"Pilot study examining the effect of cholesterol lowering on platelet nitric oxide responsiveness and arterial stiffness in subjects with isolated mild hypercholesterolaemia","volume":"30","author":"Stepien","year":"2003","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_25","first-page":"202","article-title":"Gender and tachycardia: Independent modulation of platelet reactivity in patients with atrial fibrillation","volume":"13","author":"Procter","year":"2016","journal-title":"J. Geriatr. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1476-5381.1985.tb09443.x","article-title":"Experimental testing of Mackay\u2019s model for functional antagonism in the isolated costo-uterus of the rat","volume":"86","author":"Henry","year":"1985","journal-title":"Br. J. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-3-642-38664-0_12","article-title":"Soluble guanylate cyclase stimulators in pulmonary hypertension","volume":"218","author":"Stasch","year":"2013","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/FJC.0000000000000167","article-title":"Hypoxic Vasospasm Mediated by cIMP: When Soluble Guanylyl Cyclase Turns Bad","volume":"65","author":"Gao","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/CIRCULATIONAHA.118.031373","article-title":"Reappraisal of Ischemic Heart Disease","volume":"138","author":"Kaski","year":"2018","journal-title":"Circulation"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.rmed.2017.05.005","article-title":"Individual dose adjustment of riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension","volume":"129","author":"Hill","year":"2017","journal-title":"Respir. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"204589402","DOI":"10.1177\/20458940211021036","article-title":"Platelets, extracellular vesicles and coagulation in pulmonary arterial hypertension","volume":"11","author":"Cullivan","year":"2021","journal-title":"Pulm. Circ."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"119334","DOI":"10.1016\/j.lfs.2021.119334","article-title":"The soluble guanylate cyclase stimulator, 1-nitro-2-phenylethane, reverses monocrotaline-induced pulmonary arterial hypertension in rats","volume":"275","author":"Roque","year":"2021","journal-title":"Life Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jaccas.2020.11.043","article-title":"Repurposing Riociguat for Treatment of Refractory Angina Resulting From Coronary Spasm","volume":"3","author":"Seitz","year":"2021","journal-title":"JACC Case Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/11\/9273\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:42:13Z","timestamp":1760125333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/11\/9273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["ijms24119273"],"URL":"https:\/\/doi.org\/10.3390\/ijms24119273","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,25]]}}}